Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03457779 · ClinicalTrials.gov registry record · NA
Pilot Study To Investigate Targetable Metabolic Pathways Sustaining Triple Negative Breast Cancer
A NA study, sponsored by Baylor Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT03457779 is a NA study that has completed, run by Baylor Research Institute. The registered enrollment target is 16 participants.
The verdict
NCT03457779, a NA study, has completed, sponsored by Baylor Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
The primary objective is to describe and discover new insights into the glucose, amino acid, and lipid metabolic dependencies of TNBC via nuclear magnetic resonance (NMR) spectroscopy analysis of in vivo \[1,2-13C\] glucose-labeled breast cancer biopsies. The secondary objectives are to correlate the dominant metabolic dependencies of TNBCs with pathologic response to preoperative chemotherapy, and with the cancers' molecular signaling pathways assessed via NGS and RPPA.
Interventions
- DIETARY_SUPPLEMENT Glucose
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2018-02-08 |
| Est. Completion | 2020-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03457779
The ClinicalTrials.gov registry entry for NCT03457779 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor Research Institute, which has 180 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Glucose is the first listed.
NCT03457779 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03457779 about?
NCT03457779 is a clinical study titled "Pilot Study To Investigate Targetable Metabolic Pathways Sustaining Triple Negative Breast Cancer". The primary objective is to describe and discover new insights into the glucose, amino acid, and lipid metabolic dependencies of TNBC via nuclear magnetic resonance (NMR) spectroscopy analysis of in vivo \[1,2-13C\] glucose-labeled breast cancer biopsies. The secondary objectives are to correlate t...
What is the current status of trial NCT03457779?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2018-02-08. Estimated completion is 2020-12-31.
What interventions are being tested in trial NCT03457779?
The interventions under investigation include: Glucose (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03457779?
This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.